Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase IIA Trial of Rosiglitazone (Avandia) for Oral Leukoplakia
Brief Summary: This phase II trial is studying how well rosiglitazone works in preventing oral cancer in patients with oral leukoplakia. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of rosiglitazone may keep cancer from forming in patients with oral leukoplakia